Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen (Heisenberg-Professur)

Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial (2020) Atreya R, Peyrin-Biroulet L, Klymenko A, Augustyn M, Bakulin I, Slankamenac D, Miheller P, et al. Journal article Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion (2020) Simon D, Tascilar K, Krönke G, Kleyer A, Zaiss M, Heppt F, Meder C, et al. Journal article Morbus Crohn und Colitis ulcerosa in der Hausarztpraxis (2020) Baer E, Jesper D, Neurath M, Atreya R Journal article Cobitolimod for Moderate-to-Severe Left-Sided Ulcerative Colitis (CONDUCT): A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial (2020) Atreya R, Peyrin-Biroulet L, Klymenko A, Augustyn M, Bakulin I, Slankamenac D, Miheller P, et al. Conference contribution Patients Receiving Cytokine Inhibitors Have Low Prevalence of SARS-CoV-2 Infection (2020) Simon D, Tascilar K, Krönke G, Kleyer A, Zaiss M, Heppt F, Meder C, et al. Conference contribution Perforations after routine biopsy in IBD patients, their management and potential risk reductions by microscopic imaging with endocytoscopy (2020) Klenske E, Hartmann A, Atreya R, Neurath M, Rath T Journal article Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF? (2020) Atreya R, Neurath M, Siegmund B Journal article, Review article Arginase expression impedes the resolution of intestinal inflammation by altering the fecal microbiome and the metabolome (2020) Baier J, Gänsbauer M, Giessler C, Arnold H, Muske M, Schleicher U, Lukassen S, et al. Journal article ILC2 Lung-Homing in Cystic Fibrosis Patients: Functional Involvement of CCR6 and Impact on Respiratory Failure (2020) Schulz-Kuhnt A, Greif V, Hildner K, Knipfer L, Döbrönti M, Zirlik S, Fuchs F, et al. Journal article Baseline levels of dynamic CD4+ T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study (2020) Allner C, Melde M, Becker E, Fuchs F, Mühl L, Klenske E, Müller L, et al. Journal article